Longitudinal Registry Including Patients Treated With Heavy Particles
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCNAO National Center of Oncological Hadrontherapy
About this trial
The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia.
By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity. This will help gathering more information on the results of particle therapy and will provide the basis for in depth evaluation of patients' outcome with respect to the delivered treatment.
Eligibility criteria
Qualifiers
Patients treated with heavy particles at Fondazione CNAO, Pavia
Patients who have the ability to understand and be willing to sign a written informed consent document
Disqualifiers
Patients or legal guardians who are unable to understand informed consent document
Trial design
Treatments tested in this trial
- Heavy-ion therapy (hadrontherapy)
Treatment groups
3,000 Participants
are divided into 8 treatment groups8
Treatment groupsSee each treatment group below.
Locations
1National Center for Oncological Hadrontherapy (CNAO)27100, Pavia Italy
Sponsors and collaborators
CNAO National Center of Oncological Hadrontherapy
Lead sponsor
Source ClinicalTrials.gov